晚期胃癌应用阿帕替尼病例报告1例
发布时间:2018-12-25 07:59
【摘要】:正患者男,70岁。2013年6月13日于北京协和医院行全胃切除胃癌根治术(D2)与食管空肠Roux-en-Y吻合术。术后病理示:胃贲门中低分化腺癌,累及胃壁全层,紧邻浆膜面,累及食管,距离食管断端最近距离0.4 cm,淋巴结转移癌(第6组0/5、胃小弯侧9/18、胃大弯侧0/9),免疫组织化学检测HER-2(+)。临床诊断:胃中低分化腺癌(pT3N3M0,ⅢB)。术后先后给予紫杉醇联合替吉奥方案3个疗程、单药希罗达方案2个疗
[Abstract]:The patient, 70 years old, underwent radical gastrectomy (D2) and esophagojejunostomy (Roux-en-Y) at Peking Union Hospital on June 13, 2013. Postoperative pathology showed that gastric cardia poorly differentiated adenocarcinoma, involving the whole layer of gastric wall, adjacent serous surface, involving esophagus, and the nearest distance from the broken end of esophagus to 0.4 cm, lymph node metastasis (group 6 0 / 5, small curvature of stomach 9 / 18), HER-2 (). Was detected by immunohistochemistry. Clinical diagnosis: pT3N3M0, 鈪,
本文编号:2390892
[Abstract]:The patient, 70 years old, underwent radical gastrectomy (D2) and esophagojejunostomy (Roux-en-Y) at Peking Union Hospital on June 13, 2013. Postoperative pathology showed that gastric cardia poorly differentiated adenocarcinoma, involving the whole layer of gastric wall, adjacent serous surface, involving esophagus, and the nearest distance from the broken end of esophagus to 0.4 cm, lymph node metastasis (group 6 0 / 5, small curvature of stomach 9 / 18), HER-2 (). Was detected by immunohistochemistry. Clinical diagnosis: pT3N3M0, 鈪,
本文编号:2390892
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2390892.html